Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA9 | Q16790 | 5/20 | 0.68 |
| ▸ | CA12 | O43570 | 4/20 | 0.68 |
| ▸ | AKR1B1 | P15121 | 2/20 | 0.68 |
| ▸ | MAOB | P27338 | 2/20 | 0.68 |
| ▸ | ALDH2 | P05091 | 1/20 | 0.68 |
| ▸ | MAOA | P21397 | 1/20 | 0.68 |
| ▸ | HSD17B3 | P37058 | 1/20 | 0.68 |
| ▸ | SORD | Q00796 | 1/20 | 0.68 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.65 |
| ▸ | NQO1 | P15559 | 1/20 | 0.58 |
| ▸ | CYP1B1 | Q16678 | 2/20 | 0.56 |
| ▸ | CYP1A1 | P04798 | 1/20 | 0.56 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.56 |
| ▸ | CA1 | P00915 | 2/20 | 0.56 |
| ▸ | HPGD | P15428 | 5/20 | 0.55 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.55 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.55 |
| ▸ | GABRP | O00591 | 1/20 | 0.53 |
| ▸ | GABRD | O14764 | 1/20 | 0.53 |
| ▸ | NPC1 | O15118 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31264770 | 1.00 | CA9 (0.68) | CA9CA12AKR1B1MAOBALDH2 | |
| SCHEMBL29182638 | 0.96 | CA9 (0.64) | CA9CA12AKR1B1MAOBALDH2 | |
| SCHEMBL5396825 | 0.88 | NQO1 (0.67) | CA9CA12AKR1B1MAOBALDH2 | |
| SCHEMBL29182639 | 0.87 | CA9 (0.54) | CA9CA12AKR1B1MAOBALDH2 | |
| SCHEMBL9845372 | 0.86 | GABRP (0.58) | CA9CA12AKR1B1MAOBALDH2 | |
| SCHEMBL1181618 | 0.86 | CA12 (0.69) | CA9CA12AKR1B1MAOBALDH2 | |
| SCHEMBL20420777 | 0.84 | CA9 (0.54) | CA9CA12AKR1B1MAOBALDH2 | |
| SCHEMBL13769543 | 0.83 | CA12 (0.70) | CA9CA12AKR1B1MAOBALDH2 | |
| SCHEMBL28053824 | 0.83 | GABRP (0.60) | CA9CA12AKR1B1MAOBALDH2 | |
| SCHEMBL28186315 | 0.83 | CA9 (0.54) | CA9CA12AKR1B1MAOBALDH2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 483 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4694880-A1 | POLYPHENOL-CONTAINING COMPOSITIONS FOR UPREGULATING GENE EXPRESSION | The Board of Trustees of the Leland Stanford Junior University (US) | 2026-02-18 | — | — | EP | claimed |
| CN-119841797-A | 3-Arylation/3-alkenylation coumarin compound, preparation method and application thereof | 云南民族大学 | 2025-04-18 | — | — | CN | claimed |
| CN-119587702-A | Pharmaceutical composition capable of improving bioavailability of oral statin drugs and application thereof | 强生化学制药厂股份有限公司 | 2025-03-11 | — | — | CN | claimed |
| WO-2024216192-A1 | POLYPHENOL-CONTAINING COMPOSITIONS FOR UPREGULATING CAMP GENE EXPRESSION | THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY (US) | 2024-10-17 | — | — | WO | claimed |
| CN-113453658-B | Method for dyeing or making up eyebrows | LVMH研究公司 | 2024-05-03 | — | — | CN | claimed |
| EP-3636600-B1 | A SORPTION COMPOSITION FOR COMPLEX WATER PURIFICATION | EWI BVBA (BE) | 2022-11-30 | — | — | EP | claimed |
| EP-3636600-A1 | A SORPTION COMPOSITION FOR COMPLEX WATER PURIFICATION | EWI bvba (BE) | 2020-04-15 | — | — | EP | claimed |
| CN-105085460-B | A kind of preparation method of 4 phenyl coumarin class compound | 浙江工业大学 | 2017-07-28 | — | — | CN | claimed |
| US-9127092-B2 | Method for producing polydienes and polydiene copolymers with reduced cold flow | BRIDGESTONE CORPORATION (JP) | 2015-09-08 | — | — | US | claimed |
| US-20140187725-A1 | METHOD FOR PRODUCING POLYDIENES AND POLYDIENE COPOLYMERS WITH REDUCED COLD FLOW | BRIDGESTONE CORPORATION (JP) | 2014-07-03 | — | — | US | claimed |
| US-20100199370-A1 | MEANS AND METHODS OF PRODUCING FRUITS WITH HIGH LEVELS OF ANTHOCYANINS AND FLAVONOLS | The State of Israel, Ministry of Agriculture & Rural Development, Agricultural Research | 2010-08-05 | — | — | US | claimed |
| EP-2131646-A2 | MEANS AND METHODS OF PRODUCING FRUITS WITH HIGH LEVELS OF ANTHOCYANINS AND FLAVONOLS | The State of Israel, Ministry of Agriculture and Rural Development, Agricultural Research Organisation, Volcani Center (IL) | 2009-12-16 | — | — | EP | claimed |
| WO-2008096354-A2 | MEANS AND METHODS OF PRODUCING FRUITS WITH HIGH LEVELS OF ANTHOCYANINS AND FLAVONOLS | THE STATE OF ISRAEL, MINISTRY OF AGRICULTURE & RURAL DEVELOPMENT, AGRICULTURAL RESEARCH ORGANIZATION, (A.R.O.), THE VOLCANL CENTER (IL) | 2008-08-14 | — | — | WO | claimed |
| EP-4223293-B1 | PHARMACEUTICAL COMPOSITION FOR TREATMENT OF PROSTATE CANCER | TOKYO METROPOLITAN GERIATRIC HOSPITAL AND INST OF GERONTOLOGY (JP) | 2026-05-27 | — | — | EP | disclosed |
| EP-4724064-A1 | COMPOSITION COMPRISING A COMBINATION OF A CORTICOSTEROID AND A FLAVONOID FOR USE IN TREATING EYE-RELATED DISEASES | South East Technological University (IE) | 2026-04-15 | — | — | EP | disclosed |
| US-20260097130-A1 | METHOD FOR TREATING NEURODEGENERATIVE DISEASES | SUNTEC MEDICAL INC (US) | 2026-04-09 | — | — | US | disclosed |
| US-6420571-B2 | Methods for preparing antiviral calanolide compounds | SARAWAK MEDICHEM PHARMACEUTICALS, INC. | 2002-07-16 | — | — | US | disclosed |
| US-6369241-B1 | MULTISTAGE REACTION OF KETOESTER WITH 1,3,5-TRIHYDROXYBENZENE TO PRODUCE DIHYDROXYOXOCOUMARONE, COUPLING AND CYCLIZATION | SARAWAK MEDICHEM PHARMACEUTICALS, INC. | 2002-04-09 | — | — | US | disclosed |
| US-20020013480-A1 | Methods for preparing antiviral calanolide compounds | SARAWAK MEDICHEM PHARMACEUTICALS, INC. | 2002-01-31 | — | — | US | disclosed |
| WO-1998025608-A1 | PHARMACEUTICAL COMPOSITIONS COMPRISING A 4-ARYLCOUMARIN FOR THE TREATMENT OF VIRAL INFECTIONS | BIO'S S.R.L. (IT) | 1998-06-18 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020013480-A1 | Methods for preparing antiviral calanolide compounds | ZC3HAV1, ZC3HAV1L, CYP8B1 | CA9 1469/4885CA12 868/4885AKR1B1 569/4885 |
| US-20260097130-A1 | METHOD FOR TREATING NEURODEGENERATIVE DISEASES | CD44, L1CAM, CD14 | CA9 3659/4885CA12 2714/4885AKR1B1 4276/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.